Kaye Jack Harry, the Executive Chairman of Davion Healthcare PLC, has made significant changes to his ownership of the company's shares. On November 19, 2026, he gifted a total of 1.6 million ordinary shares, which has implications for both his personal stake and the company's leadership structure.
This transaction is noteworthy as it reflects a shift in ownership dynamics within Davion Healthcare. Following the gifts, Harry retains 8,668,948 ordinary shares, indicating a substantial reduction in his direct ownership. Such actions can influence investor confidence and highlight trends in corporate governance.
Background
Davion Healthcare PLC is a company involved in the surgical and medical instruments and apparatus sector. The company is incorporated in Ireland and operates under the Central Index Key (CIK) number 0002039072. It is publicly traded, with the ticker symbol DAVI.
Recent filings by the company include a Schedule 13D/A on August 11, 2026, and a Schedule 13D on April 17, 2026, indicating ongoing activities related to ownership and shareholder disclosures.
What the Filing Says
"On November 19, 2026, the Reporting Person made four separate bona fide gifts of ordinary shares of Davion Healthcare Plc, representing an aggregate disposition of 1,600,000 ordinary shares."
The filing further clarifies that the gifts were made without any consideration, meaning Harry did not receive any payment in return for the shares. Following these transactions, he no longer retains voting power, investment power, or any pecuniary interest in the gifted shares.
Impact
This development may affect various stakeholders, including investors and other shareholders of Davion Healthcare. The reduction in Harry's ownership stake could raise questions about the company's future direction and governance. As an influential figure in the company, his decisions are closely watched by the market.
What's Next
The filing does not say what happens next regarding further ownership changes or corporate actions from Davion Healthcare.
Read Next
Beberman Perry S acquires 10,000 shares of preferred stock
Filana Therapeutics CEO Increases Stake with Share Purchase
Translational Development Acquisition Corp. amends merger deal
Contango Silver & Gold director Juneau acquires 9,705 shares
CEO Joel M. Block acquires over 46,000 shares in DarkHorse
Williams Gregg Boosts Stake in Vivani Medical with New Purchases









